Skip to content
BOLUS

Signal from the log

EnginZyme

75 MSEK · Sweden · Biotech

EnginZyme fixe des enzymes sur un support solide pour fabriquer des molécules sans organisme vivant. La société vise un coût et une empreinte inférieurs à ceux de la chimie de synthèse classique, et dit passer de la recherche à la commercialisation.

Verified

Announced on , logged by the watch of 23 September 2026.

Operation
Funding round
Announced amount
75 MSEK
Country
Sweden
Sector
Biotech

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Lotus One Investment , Valquest Partners Europe , with Sofinnova Partners , Stiftelsen Industrifonden , Navigare Ventures , Almi Invest GreenTech

What is missing before publishing
  • The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source businesswire
Logged on 23 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).